English | 简体中文 | 繁體中文 | 한국어 | 日本語
 Latest Press Releases
Tuesday, October 22, 2024
Everest Medicines Announces Positive Results of Complete Chinese Subpopulation Data from the NEFECON Global Phase 3 NefIgArd Clinical Trial
11:52 HKT/SGT
雲頂新耀宣佈耐賦康®NefIgArd III期全球臨床試驗完整中國亞組資料的積極結果
11:43 HKT/SGT
云顶新耀宣布耐赋康(R) NefIgArd III期全球临床试验完整中国亚组数据的积极结果
11:37 HKT/SGT
富士通、世界的なGPU不足の解決に向け、AI処理におけるGPUの演算効率を高めるミドルウェア技術「AI computing broker」の提供を開始
10:30 HKT/SGT
Fujitsu launches AI computing broker middleware to address global GPU shortages and enhance AI processing efficiency
09:41 HKT/SGT
Global Technology Distribution Council Welcomes Redington Limited
08:00 HKT/SGT
Femto Technologies Inc. Announces Consolidation of Enhanced Voting Preference Shares
08:00 HKT/SGT
Monday, October 21, 2024
Acrometa Group to Divest Its Life Sciences Business, Pursue New Business Opportunities in the Region
22:50 HKT/SGT
GMG Provides Business Update on Australian Federal Government Engagement
20:29 HKT/SGT
FishWar Officially Powered by Sei: Elevating the GameFi Experience
20:00 HKT/SGT
Hong Kong International Wine & Spirits Fair opens next month
19:39 HKT/SGT
康哲藥業入選2024年度「中國醫藥上市公司ESG競爭力」系列榜單
19:18 HKT/SGT
康哲药业入选2024年度“中国医药上市公司ESG竞争力”系列榜单
19:15 HKT/SGT
FishWar Officially Powered by Sei: Elevating the GameFi Experience
19:00 HKT/SGT
三菱重工、人事異動を発表
16:00 HKT/SGT
JCBと富士通、中央銀行デジタル通貨を活用した、異なるキャッシュレスサービス間での取引実現に向け、ホワイトペーパーを発行
16:00 HKT/SGT
Majority of Singapore Employees Comfortable Discussing Mental Health at Work, foundit Survey Reveals
16:00 HKT/SGT
GTJAI Wins Multiple Awards at HKQAA Hong Kong Green and Sustainable Finance Awards 2024
15:48 HKT/SGT
國泰君安國際榮獲HKQAA香港綠色和可持續金融大奬 2024多項殊榮
15:44 HKT/SGT
国泰君安国际荣获HKQAA香港绿色和可持续金融大奬 2024多项殊荣
15:40 HKT/SGT
Learn & Get Inspired at the Global STEM Confex
15:00 HKT/SGT
TOYOTA GAZOO Racing closes the gap before the final round
12:27 HKT/SGT
Everest Medicines Announces Taiwan TFDA Approval of NEFECON for the Treatment of Primary IgA Nephropathy
12:19 HKT/SGT
云顶新耀宣布中国台湾地区药政部门批准全球首个对因治疗IgA肾病药物耐赋康®的新药上市许可申请
12:08 HKT/SGT
雲頂新耀宣佈中國台灣地區藥政部門批准全球首個對因治療IgA腎病藥物耐賦康®的新藥上市許可申請
11:44 HKT/SGT
Ching Lee Holdings practices CSR to promote sustainability in the construction industry
11:12 HKT/SGT
JCB and GHL Expand Payment Options across Malaysia, Thailand and the Philippines
11:00 HKT/SGT
正利控股推动建筑业可持续发展与企业社会责任实践
10:56 HKT/SGT
正利控股推動建築業可持續發展與企業社會責任實踐
10:01 HKT/SGT
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
10:00 HKT/SGT
Friday, October 18, 2024
中信國際電訊CPC 成就「+AI到AI+」實現「技術賦能」結合「數據賦能」
22:28 HKT/SGT
Mitsubishi Corporation (MC) to invest in Ayala joint venture with stake in Mynt
22:05 HKT/SGT
MHI Receives Order to Supply MOX Fuel Assemblies for Unit 3 of Genkai Nuclear Power Station, Kyushu Electric Power Co. Inc.
21:59 HKT/SGT
CITIC Telecom CPC Propels '+AI to AI+'
21:58 HKT/SGT
中信国际电讯CPC 成就 “+AI 到 AI+” 实现 “技术赋能” 结合 “数据赋能”
21:19 HKT/SGT
The 15th Turkish-Arab Economic Forum (TAFF 2024) took place at the Four Seasons Bosphorus Hotel in Istanbul
19:00 HKT/SGT
Everest Medicines' Stock Price Rises by 20% as Profit Potential Drives Valuation Recovery
18:37 HKT/SGT
云顶新耀股价升两成 盈利潜力助力估值修复
18:31 HKT/SGT
雲頂新耀股價升兩成 盈利潛力助力估值修復
18:28 HKT/SGT
China Medical System: First Ruxolitinib Cream's Prescriptions for Vitiligo Issued in the Greater Bay Area
15:00 HKT/SGT
康哲藥業:蘆可替尼乳膏(白癜風)大灣區首批處方落地
14:54 HKT/SGT
Hitachi Receives Order for 56 Elevators and Escalators for CRC The Flagship in Noida, India
14:50 HKT/SGT
康哲药业:芦可替尼乳膏(白癜风)大湾区首批处方落地
14:44 HKT/SGT
MHI Thermal Systems Receives Order for Large-scale Centrifugal Chillers from Empower for its District Cooling Plants in Dubai, UAE
10:20 HKT/SGT
富士通と帝京大学がXRや空間コンピューティング、生成AIを活用し、生活習慣改善を促進するUXの共同研究を開始
10:20 HKT/SGT
 ACN Search:
 
Viberse launches Tango: A playful way to meet new faces worldwide
 
Daily Newsletter
Browse Press Releases
Press Releases by Industry »
Press Releases by Language »
Multimedia Press Releases »
Events newsroom »
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575